Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

导出 LinkOut

翻译打印收藏纠错

作者： Philip J,Mease ^[1] ; Alexis,Ogdie ^[2] ; John,Tesser ^[3] ; Natalie J,Shiff ^[4] ; Iris,Lin ^[5] ; Soumya D,Chakravarty ^[4] ; Michael,Kelleman ^[4] ; Rhiannon,Dodge ^[6] ; Robert R,McLean ^[7] ; Aaron,Broadwell ^[7] ; Arthur,Kavanaugh ^[7] ; Joseph F,Merola ^[8]

作者单位： Swedish Medical Center/Providence St. Joseph Health and University of Washington, 601 Broadway, Ste 600, Seattle, WA, 98122, USA. pmease@philipmease.com. ^[1] University of Pennsylvania School of Medicine, Philadelphia, PA, USA. ^[2] Arizona Arthritis and Rheumatology Associates, P.C., Phoenix, AZ, USA. ^[3] Janssen Scientific Affairs, LLC, Horsham, PA, USA. ^[4] University of Saskatchewan, Saskatoon, Canada. ^[5] Drexel University College of Medicine, Philadelphia, PA, USA. ^[6] CorEvitas, LLC, Waltham, MA, USA. ^[7] Rheumatology and Osteoporosis Specialists, Shreveport, LA, USA. ^[8] University of California San Diego, La Jolla, CA, USA. ^[9] Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ^[10]

关键词 Biologics Guselkumab Psoriatic arthritis Real-world evidence

DOI 10.1007/s40744-023-00582-w

PMID 37597159

发布时间 2024-05-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Rheumatology and therapy

2023年10卷6期

1479-1501页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Rheumatology and therapy

相似文献

Rheumatology and therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Rheumatology and therapy

相似文献

Rheumatology and therapy

相关期刊

检索历史清除